Click for best price
GCSF GCSF Biosimilars Market Size, Share 2022
G-CSF, which is also known as filgrastim, is a growth factor used to aid the recovery of bone marrow after chemotherapy treatment for cancer, especially in patients with neutropenia (low white blood cell count in the blood), which causes reduced resistance to infections. It can also be used to stimulate mobilization of haematopoietic stem cells for collection and transplantation.
This report contains market size and forecasts of G-CSF and G-CSF Biosimilars in global, including the following market information:
Global top five G-CSF and G-CSF Biosimilars companies in 2021 (%)
The global G-CSF and G-CSF Biosimilars market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blood Disorders Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of G-CSF and G-CSF Biosimilars include Pfizer, Novartis, Roche, Merck & Co., Sanofi, Johnson & Johnson, Gilead Science, GlaxoSmithKline and AbbVie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the G-CSF and G-CSF Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global G-CSF and G-CSF Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global G-CSF and G-CSF Biosimilars Market Segment Percentages, by Type, 2021 (%)
- Blood Disorders
- Oncology Diseases
- Chronic And Autoimmune Diseases
- Growth Hormone Deficiencies
Global G-CSF and G-CSF Biosimilars Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global G-CSF and G-CSF Biosimilars Market Segment Percentages, by Application, 2021 (%)
- Human Growth Hormone
- Erythropoietin
- Monoclonal Antibodies
- Insulin
- Interferon
Global G-CSF and G-CSF Biosimilars Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global G-CSF and G-CSF Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies G-CSF and G-CSF Biosimilars revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies G-CSF and G-CSF Biosimilars revenues share in global market, 2021 (%)
- Key companies G-CSF and G-CSF Biosimilars sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies G-CSF and G-CSF Biosimilars sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Novartis
- Roche
- Merck & Co.
- Sanofi
- Johnson & Johnson
- Gilead Science
- GlaxoSmithKline
- AbbVie
- Amgen
- AstraZeneca
- Bayer
| Report Attributes |
Report Details |
| Report Title |
G-CSF and G-CSF Biosimilars Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 G-CSF and G-CSF Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global G-CSF and G-CSF Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global G-CSF and G-CSF Biosimilars Overall Market Size
2.1 Global G-CSF and G-CSF Biosimilars Market Size: 2021 VS 2028
2.2 Global G-CSF and G-CSF Biosimilars Revenue, Prospects & Forecasts: 2017-2028
2.3 Global G-CSF and G-CSF Biosimilars Sales: 2017-2028
3 Company Landscape
3.1 Top G-CSF and G-CSF Biosimilars Players in Global Market
3.2 Top Global G-CSF and G-CSF Biosimilars Companies Ranked by Revenue
3.3 Global G-CSF and G-CSF Biosimilars Revenue by Companies
3.4 Global G-CSF and G-CSF Biosimilars Sales by Companies
3.5 Global G-CSF and G-CSF Biosimilars Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 G-CSF and G-CSF Biosimilars Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers G-CSF and G-CSF Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 G-CSF and G-CSF Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 G-CSF and G-CSF Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 G-CSF and G-CSF Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global G-CSF and G-CSF Biosimilars Market Size Markets, 2021 & 2028
4.1.2 Blood Disorders
4.1.3 Oncology Diseases
4.1.4 Chronic And Autoimmune Diseases
4.1.5 Growth Hormone Deficiencies
4.2 By Type - Global G-CSF and G-CSF Biosimilars Revenue & Forecasts
4.2.1 By Type - Global G-CSF and G-CSF Biosimilars Revenue, 2017-2022
4.2.2 By Type - Global G-CSF and G-CSF Biosimilars Revenue, 2023-2028
4.2.3 By Type - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
4.3 By Type - Global G-CSF and G-CSF Biosimilars Sales & Forecasts
4.3.1 By Type - Global G-CSF and G-CSF Biosimilars Sales, 2017-2022
4.3.2 By Type - Global G-CSF and G-CSF Biosimilars Sales, 2023-2028
4.3.3 By Type - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
4.4 By Type - Global G-CSF and G-CSF Biosimilars Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global G-CSF and G-CSF Biosimilars Market Size, 2021 & 2028
5.1.2 Human Growth Hormone
5.1.3 Erythropoietin
5.1.4 Monoclonal Antibodies
5.1.5 Insulin
5.1.6 Interferon
5.2 By Application - Global G-CSF and G-CSF Biosimilars Revenue & Forecasts
5.2.1 By Application - Global G-CSF and G-CSF Biosimilars Revenue, 2017-2022
5.2.2 By Application - Global G-CSF and G-CSF Biosimilars Revenue, 2023-2028
5.2.3 By Application - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
5.3 By Application - Global G-CSF and G-CSF Biosimilars Sales & Forecasts
5.3.1 By Application - Global G-CSF and G-CSF Biosimilars Sales, 2017-2022
5.3.2 By Application - Global G-CSF and G-CSF Biosimilars Sales, 2023-2028
5.3.3 By Application - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
5.4 By Application - Global G-CSF and G-CSF Biosimilars Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global G-CSF and G-CSF Biosimilars Market Size, 2021 & 2028
6.2 By Region - Global G-CSF and G-CSF Biosimilars Revenue & Forecasts
6.2.1 By Region - Global G-CSF and G-CSF Biosimilars Revenue, 2017-2022
6.2.2 By Region - Global G-CSF and G-CSF Biosimilars Revenue, 2023-2028
6.2.3 By Region - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
6.3 By Region - Global G-CSF and G-CSF Biosimilars Sales & Forecasts
6.3.1 By Region - Global G-CSF and G-CSF Biosimilars Sales, 2017-2022
6.3.2 By Region - Global G-CSF and G-CSF Biosimilars Sales, 2023-2028
6.3.3 By Region - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America G-CSF and G-CSF Biosimilars Revenue, 2017-2028
6.4.2 By Country - North America G-CSF and G-CSF Biosimilars Sales, 2017-2028
6.4.3 US G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.4.4 Canada G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.4.5 Mexico G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe G-CSF and G-CSF Biosimilars Revenue, 2017-2028
6.5.2 By Country - Europe G-CSF and G-CSF Biosimilars Sales, 2017-2028
6.5.3 Germany G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.5.4 France G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.5.5 U.K. G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.5.6 Italy G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.5.7 Russia G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.5.8 Nordic Countries G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.5.9 Benelux G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia G-CSF and G-CSF Biosimilars Revenue, 2017-2028
6.6.2 By Region - Asia G-CSF and G-CSF Biosimilars Sales, 2017-2028
6.6.3 China G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.6.4 Japan G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.6.5 South Korea G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.6.6 Southeast Asia G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.6.7 India G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America G-CSF and G-CSF Biosimilars Revenue, 2017-2028
6.7.2 By Country - South America G-CSF and G-CSF Biosimilars Sales, 2017-2028
6.7.3 Brazil G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.7.4 Argentina G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Sales, 2017-2028
6.8.3 Turkey G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.8.4 Israel G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.8.5 Saudi Arabia G-CSF and G-CSF Biosimilars Market Size, 2017-2028
6.8.6 UAE G-CSF and G-CSF Biosimilars Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer G-CSF and G-CSF Biosimilars Major Product Offerings
7.1.4 Pfizer G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis G-CSF and G-CSF Biosimilars Major Product Offerings
7.2.4 Novartis G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche G-CSF and G-CSF Biosimilars Major Product Offerings
7.3.4 Roche G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Merck & Co.
7.4.1 Merck & Co. Corporate Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Major Product Offerings
7.4.4 Merck & Co. G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.4.5 Merck & Co. Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi G-CSF and G-CSF Biosimilars Major Product Offerings
7.5.4 Sanofi G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.5.5 Sanofi Key News
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporate Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Major Product Offerings
7.6.4 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.6.5 Johnson & Johnson Key News
7.7 Gilead Science
7.7.1 Gilead Science Corporate Summary
7.7.2 Gilead Science Business Overview
7.7.3 Gilead Science G-CSF and G-CSF Biosimilars Major Product Offerings
7.7.4 Gilead Science G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.7.5 Gilead Science Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Major Product Offerings
7.8.4 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 AbbVie
7.9.1 AbbVie Corporate Summary
7.9.2 AbbVie Business Overview
7.9.3 AbbVie G-CSF and G-CSF Biosimilars Major Product Offerings
7.9.4 AbbVie G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.9.5 AbbVie Key News
7.10 Amgen
7.10.1 Amgen Corporate Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen G-CSF and G-CSF Biosimilars Major Product Offerings
7.10.4 Amgen G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.10.5 Amgen Key News
7.11 AstraZeneca
7.11.1 AstraZeneca Corporate Summary
7.11.2 AstraZeneca G-CSF and G-CSF Biosimilars Business Overview
7.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Major Product Offerings
7.11.4 AstraZeneca G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.11.5 AstraZeneca Key News
7.12 Bayer
7.12.1 Bayer Corporate Summary
7.12.2 Bayer G-CSF and G-CSF Biosimilars Business Overview
7.12.3 Bayer G-CSF and G-CSF Biosimilars Major Product Offerings
7.12.4 Bayer G-CSF and G-CSF Biosimilars Sales and Revenue in Global (2017-2022)
7.12.5 Bayer Key News
8 Global G-CSF and G-CSF Biosimilars Production Capacity, Analysis
8.1 Global G-CSF and G-CSF Biosimilars Production Capacity, 2017-2028
8.2 G-CSF and G-CSF Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global G-CSF and G-CSF Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 G-CSF and G-CSF Biosimilars Supply Chain Analysis
10.1 G-CSF and G-CSF Biosimilars Industry Value Chain
10.2 G-CSF and G-CSF Biosimilars Upstream Market
10.3 G-CSF and G-CSF Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 G-CSF and G-CSF Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of G-CSF and G-CSF Biosimilars in Global Market
Table 2. Top G-CSF and G-CSF Biosimilars Players in Global Market, Ranking by Revenue (2021)
Table 3. Global G-CSF and G-CSF Biosimilars Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global G-CSF and G-CSF Biosimilars Revenue Share by Companies, 2017-2022
Table 5. Global G-CSF and G-CSF Biosimilars Sales by Companies, (K Units), 2017-2022
Table 6. Global G-CSF and G-CSF Biosimilars Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers G-CSF and G-CSF Biosimilars Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers G-CSF and G-CSF Biosimilars Product Type
Table 9. List of Global Tier 1 G-CSF and G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 G-CSF and G-CSF Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2017-2022
Table 15. By Type - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2023-2028
Table 16. By Application ? Global G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2017-2022
Table 20. By Application - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2023-2028
Table 21. By Region ? Global G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global G-CSF and G-CSF Biosimilars Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2017-2022
Table 25. By Region - Global G-CSF and G-CSF Biosimilars Sales (K Units), 2023-2028
Table 26. By Country - North America G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America G-CSF and G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 29. By Country - North America G-CSF and G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 30. By Country - Europe G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe G-CSF and G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 33. By Country - Europe G-CSF and G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 34. By Region - Asia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia G-CSF and G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 37. By Region - Asia G-CSF and G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 38. By Country - South America G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America G-CSF and G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 41. By Country - South America G-CSF and G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer G-CSF and G-CSF Biosimilars Product Offerings
Table 48. Pfizer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis G-CSF and G-CSF Biosimilars Product Offerings
Table 51. Novartis G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche G-CSF and G-CSF Biosimilars Product Offerings
Table 54. Roche G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Merck & Co. Corporate Summary
Table 56. Merck & Co. G-CSF and G-CSF Biosimilars Product Offerings
Table 57. Merck & Co. G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Sanofi Corporate Summary
Table 59. Sanofi G-CSF and G-CSF Biosimilars Product Offerings
Table 60. Sanofi G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Johnson & Johnson Corporate Summary
Table 62. Johnson & Johnson G-CSF and G-CSF Biosimilars Product Offerings
Table 63. Johnson & Johnson G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Gilead Science Corporate Summary
Table 65. Gilead Science G-CSF and G-CSF Biosimilars Product Offerings
Table 66. Gilead Science G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. GlaxoSmithKline Corporate Summary
Table 68. GlaxoSmithKline G-CSF and G-CSF Biosimilars Product Offerings
Table 69. GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. AbbVie Corporate Summary
Table 71. AbbVie G-CSF and G-CSF Biosimilars Product Offerings
Table 72. AbbVie G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Amgen Corporate Summary
Table 74. Amgen G-CSF and G-CSF Biosimilars Product Offerings
Table 75. Amgen G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. AstraZeneca Corporate Summary
Table 77. AstraZeneca G-CSF and G-CSF Biosimilars Product Offerings
Table 78. AstraZeneca G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Bayer Corporate Summary
Table 80. Bayer G-CSF and G-CSF Biosimilars Product Offerings
Table 81. Bayer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. G-CSF and G-CSF Biosimilars Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global G-CSF and G-CSF Biosimilars Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global G-CSF and G-CSF Biosimilars Production by Region, 2017-2022 (K Units)
Table 85. Global G-CSF and G-CSF Biosimilars Production by Region, 2023-2028 (K Units)
Table 86. G-CSF and G-CSF Biosimilars Market Opportunities & Trends in Global Market
Table 87. G-CSF and G-CSF Biosimilars Market Drivers in Global Market
Table 88. G-CSF and G-CSF Biosimilars Market Restraints in Global Market
Table 89. G-CSF and G-CSF Biosimilars Raw Materials
Table 90. G-CSF and G-CSF Biosimilars Raw Materials Suppliers in Global Market
Table 91. Typical G-CSF and G-CSF Biosimilars Downstream
Table 92. G-CSF and G-CSF Biosimilars Downstream Clients in Global Market
Table 93. G-CSF and G-CSF Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. G-CSF and G-CSF Biosimilars Segment by Type
Figure 2. G-CSF and G-CSF Biosimilars Segment by Application
Figure 3. Global G-CSF and G-CSF Biosimilars Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global G-CSF and G-CSF Biosimilars Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global G-CSF and G-CSF Biosimilars Revenue, 2017-2028 (US$, Mn)
Figure 7. G-CSF and G-CSF Biosimilars Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by G-CSF and G-CSF Biosimilars Revenue in 2021
Figure 9. By Type - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 10. By Type - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 11. By Type - Global G-CSF and G-CSF Biosimilars Price (USD/Unit), 2017-2028
Figure 12. By Application - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 13. By Application - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 14. By Application - Global G-CSF and G-CSF Biosimilars Price (USD/Unit), 2017-2028
Figure 15. By Region - Global G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 16. By Region - Global G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 17. By Country - North America G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 18. By Country - North America G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 19. US G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 20. Canada G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 23. By Country - Europe G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 24. Germany G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 25. France G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 27. Italy G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 28. Russia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 32. By Region - Asia G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 33. China G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 34. Japan G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 37. India G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 39. By Country - South America G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 40. Brazil G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa G-CSF and G-CSF Biosimilars Sales Market Share, 2017-2028
Figure 44. Turkey G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 45. Israel G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 47. UAE G-CSF and G-CSF Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 48. Global G-CSF and G-CSF Biosimilars Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production G-CSF and G-CSF Biosimilars by Region, 2021 VS 2028
Figure 50. G-CSF and G-CSF Biosimilars Industry Value Chain
Figure 51. Marketing Channels
